Novo Nordisk - Oxford Fellowship Programme
The Novo Nordisk – Oxford Fellowship Programme aims to support the development of a new generation of exceptional researchers in the field of diabetes and other cardiometabolic diseases, who will become future leaders in the field.
2023 CALL FOR APPLICATIONS IS NOW OPEN
We are currently advertising five Postdoctoral Research Fellowships with a closing date of midday on Wednesday 26 April
The Novo Nordisk – Oxford Fellowship Programme is focused on research in diabetes, cardiometabolism, liver and renal disease. It aims to support the development of a new generation of exceptional early career researchers, who will become future leaders in the field, while further developing scientific excellence and ultimately improving the lives of patients. We offer prestigious 3-year postdoctoral research fellowship positions in research projects that span the translational spectrum, from basic biological research through to clinical application.
What we offer
We offer fellows a cutting edge research project based at the University of Oxford, which is supervised by world-leading researchers in the field of diabetes and other cardiometabolic diseases. In addition, each fellow is given a mentor or supervisor at Novo Nordisk. There is also the opportunity to spend time in the laboratories of Novo Nordisk (both in Oxford and Denmark). This distribution of time will depend on the fellow's specific project. Fellows will therefore get an insight into research in both academia and industry.
Developing a metabolic clearance rate framework as a translational analysis approach for hyperpolarized 13C magnetic resonance imaging.
Grist JT. et al, (2023), Sci Rep, 13
Reversible pH-responsive MRI contrast with paramagnetic polymer micelles.
Ellis CM. et al, (2023), Chem Commun (Camb)
Cardiometabolic risk factors vary with age differently in females and males
Miller JJ. and Heather LC., (2022), Nature Cardiovascular Research
Direct observation of the molecular mechanism underlying protein polymerization.
Hundt N. et al, (2022), Sci Adv, 8